Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Total Current Liabilities (2016 - 2025)

Medifast (MED) has disclosed Total Current Liabilities for 16 consecutive years, with $43.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities fell 33.04% year-over-year to $43.0 million, compared with a TTM value of $43.0 million through Dec 2025, down 33.04%, and an annual FY2025 reading of $43.0 million, down 33.04% over the prior year.
  • Total Current Liabilities was $43.0 million for Q4 2025 at Medifast, down from $46.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $188.2 million in Q2 2022 and bottomed at $43.0 million in Q4 2025.
  • Average Total Current Liabilities over 5 years is $111.4 million, with a median of $112.5 million recorded in 2023.
  • The sharpest move saw Total Current Liabilities skyrocketed 77.1% in 2021, then tumbled 41.41% in 2024.
  • Year by year, Total Current Liabilities stood at $169.8 million in 2021, then fell by 17.04% to $140.9 million in 2022, then crashed by 34.49% to $92.3 million in 2023, then tumbled by 30.49% to $64.2 million in 2024, then tumbled by 33.04% to $43.0 million in 2025.
  • Business Quant data shows Total Current Liabilities for MED at $43.0 million in Q4 2025, $46.7 million in Q3 2025, and $46.2 million in Q2 2025.